GE Healthcare announced today that the U.S. Food and Drug Administration (FDA) has designated for priority review the New Drug Application (NDA) for AdreView.
Exercises enhances life of Breast Cancer survivors after treatment
A study of more than 500 breast cancer survivors shows that it’s never too late to reap the benefits of an exercise program. The study, found that breast cancer survivors who pursued physical activity during and after treatment reported an improved quality of life, including less fatigue and pain.
A New Concept in Annuloplasty for Valve Repair: the Biodegradable Ring
The Kalangos® ring was developed for pediatric annuloplasty to preserve the growth potential of the child’s heart. It is also suitable for adult annuloplasty by extension. This now commercially available device made of biodegradable polydioxanone induces the growth of autologous fibrous tissue that reinforces the deficient annulus.
Companies to focus on their service centers to strengthen customer support and provide easier access
The Healthcare industry is one of the largest industries catering to the medical needs of innumerable people around the globe. Consuming over 10 percent of the gross domestic product of most developed nations, healthcare is an enormous part of a country’s economy.
A New Approach to Managing GORD
Until now, assessing the progress of treatment for Gastro-Oesaphageal Reflux Disease (GORD) has relied primarily on an assessment of oesophageal healing. Documenting GORD therapy success is a difficult task, as mucosal damage does not always correspond with the severity of symptoms.1 In addition, 70% of all patients with GORD symptoms have endoscopic-negative GORD.2,3
Bone Substitutes to Replace Transplantation?
An osteoconductive and osteoinductive biphasic ceramic replacement for bone loss could be an alternative to grafts. The safety and efficacy of this material has been shown in preclinical and clinical trials, demonstrating its suitability.